Skip to main content
SpringerLink
Log in
Book cover

Chemical Mutagens pp 57–82Cite as

Correlation Between Teratogenic and Mutagenic Effects of Chemicals in Mammals

  • Chapter

Abstract

Teratology is the discipline dealing with the causes and the development of congenital malformations. As used here, congenital malformations are gross structural anomalies of prenatal origin. In the widest sense, teratogens include endogenous factors (i.e., point mutations or chromosomal aberrations) as well as exogenous agents. There has been a tendency to forget these facts, as teratology has come to be associated with “environment,” whereas properly it should carry no such connotation.

Supported in part by NIH grant HD03502.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. J. G. Wilson, Teratogenic interaction of chemical agents in the rat, J. Pharmacol Exp. Therap. 144, 429–436 (1964).

    CAS  Google Scholar 

  2. H. Kalter, in “Teratology: Principles and Techniques” (J. G. Wilson and J. Warkany, eds.) pp. 57–80, University of Chicago Press, Chicago (1965).

    Google Scholar 

  3. M. J. Edwards, Congenital defects in guinea pigs: Fetal resorptions, abortions, and malformations following induced hyperthermia during early gestation, Teratology 2, 313–328 (1969).

    Article  PubMed  CAS  Google Scholar 

  4. L. B. Russell, in “Radiation Biology” (A. Hollaender, ed.) Vol. 1, Part 2, pp. 861–918, McGraw-Hill, New York (1954).

    Google Scholar 

  5. W. L. Russell, Studies in mammalian radiation genetics, Nucleonics 23, 53–56, 62 (Jan., 1965).

    Google Scholar 

  6. S. P. Hicks and C. J. D’Amato, Effects of ionizing radiations on mammalian development, Adv. Teratol. 1, 196–250 (1966).

    Google Scholar 

  7. E. L. Green, Genetic effects of radiation on mammalian populations, Ann. Rev. Genet. 2, 87–120 (1968).

    Article  Google Scholar 

  8. H. Kalter, “Teratology of the Central Nervous System, ” University of Chicago Press, Chicago (1968).

    Google Scholar 

  9. L. B. Russell, Chromosome aberrations in experimental animals, Prog. Med. Genet. 2, 230–294 (1962).

    Google Scholar 

  10. A. J. Bateman, Testing chemicals for mutagenicity in a mammal, Nature 210, 205–206 (1966).

    Article  PubMed  CAS  Google Scholar 

  11. G. Röhrborn, Mutagenicity tests in mice. I. The dominant lethal method and the control problem, Humangenetik 6, 345–361 (1968).

    PubMed  Google Scholar 

  12. W. L. Russell, X-ray-induced mutations in mice, Cold Spring Harbor Symp. Quant. Biol. 16, 327–336 (1951).

    Article  PubMed  CAS  Google Scholar 

  13. G. D. Snell, X-ray sterility in the male house mouse, J. Exp. Zool. 65, 421–441 (1933).

    Article  Google Scholar 

  14. G. D. Snell, The induction by X-rays of hereditary changes in mice, Genetics 20, 545–567 (1935).

    PubMed  CAS  Google Scholar 

  15. H. H. Strandskov, Effects of X-rays in an inbred strain of guinea pigs, J. Exp. Zool. 63, 175–202 (1932).

    Article  Google Scholar 

  16. W. L. Russell, in “Radiation Biology” (A. Hollaender, ed.) Vol. 1, Part 2, pp. 825–859, McGraw-Hill, New York (1954).

    Google Scholar 

  17. P. C. Koller and C. A. Auerbach, Chromosome breakage and sterility in the mouse, Nature 148, 501–502 (1941).

    Article  Google Scholar 

  18. P. C. Koller, Segmental interchange in mice, Genetics 29, 247–263 (1944).

    PubMed  CAS  Google Scholar 

  19. G. D. Snell, An analysis of translocations in the mouse, Genetics 31, 157–180 (1946).

    Google Scholar 

  20. A. B. Griffen, in “Biology of the Laboratory Mouse” (E. L. Green, ed.) 2nd ed., pp. 51–85, McGraw-Hill, New York (1966).

    Google Scholar 

  21. C. Auerbach, The chemical production of mutations, Science 158, 1141–1147 (1967).

    Article  PubMed  CAS  Google Scholar 

  22. H. Jackson, The effects of alkylating agents on fertility, Brit. Med. Bull. 20, 107–114 (1964).

    PubMed  CAS  Google Scholar 

  23. A. Fave, Les embryopathies provoquées chez les mammifères, Thérapie 19, 43–164 (1964).

    PubMed  CAS  Google Scholar 

  24. H. Nishimura, “Chemistry and Prevention of Congenital Anomalies, ” Charles C Thomas, Springfield, I11. (1964).

    Google Scholar 

  25. D. A. Karnofsky, Drugs as teratogens in animals and man, Ann. Rev. Pharmacol. 5, 447–472 (1965).

    Article  CAS  Google Scholar 

  26. F. Vichi, P. L. Masi, P. Pierleoni, S. Orlando, L. Pagni, and I. Tollaro, “I Fattori Metagenetici Esogeni nelle Malformazioni Congenita (Oro-maxillofaciali): Teratogenesi Sperimentale e Riferimenti Clinici, ” Minerva Medica, Saluzzo (1966).

    Google Scholar 

  27. S. Chaube and M. L. Murphy, Teratogenic effects of the recent drugs active in cancer chemotherapy, Adv. Teratol. 3, 181–237 (1968).

    Google Scholar 

  28. M. L. Murphy, A. Del Moro, and C. Lacon, Comparative effects of five polyfunctional alkylating agents on the rat fetus, with additional notes on the chick embryo, Ann. N.Y. Acad. Sci. 68, 762–781 (1958).

    Article  PubMed  CAS  Google Scholar 

  29. D. S. Falconer, B. M. Slizynski, and C. Auerbach, Genetical effects of nitrogen mustard in the house mouse, J. Genet. 51, 81–88 (1952).

    Article  CAS  Google Scholar 

  30. B. M. Cattanach, Chemically induced mutations in mice, Mutation Res. 3, 346–353 (1966).

    PubMed  CAS  Google Scholar 

  31. G. Röhrborn and F. Vogel, A search for dominant mutations in F1 progeny of male mice treated with trenimone (triethyleneiminobenzoquinone-1, 4), Humangenetik 7, 43–50 (1969).

    Article  PubMed  Google Scholar 

  32. B. M. Cattanach, The sensitivity of the mouse testis to the mutagenic action of triethylenemelamine, Z. Vererb. 90, 1–6 (1959).

    Article  CAS  Google Scholar 

  33. B. M. Cattanach, Induction of translocations in mice by triethylenemelamine, Nature 180, 1364–1365 (1957).

    Article  PubMed  CAS  Google Scholar 

  34. G. D. Snell, Induction by roentgen rays of hereditary changes in mice, Radiology, 36, 189–194 (1941).

    Google Scholar 

  35. W. L. Russell and L. B. Russell, The genetic and phenotypic characteristics of radiation-induced mutations in mice, Radiat. Res. Suppl. 1, 296–305 (1959).

    Article  Google Scholar 

  36. C. Ockey, T. Hsu, and L. Richardson, Chromosome damage induced by 5-fluoro-2′-deoxyuridine (FUDR) in relation to the cell cycle of the Chinese hamster, J. Nat. Cancer Inst. 40, 465–475 (1968).

    Google Scholar 

  37. G. D. Snell, E. Bodemann, and W. Hollander, A translocation in the house mouse and its effect on development, J. Exp. Zool. 67, 93–104 (1934).

    Article  Google Scholar 

  38. E. M. Otis, Prenatal Mortality Rates of Seventeen Radiation Induced Translocations in Mice, University of Rochester Atomic Energy Report UR-291 (1953).

    Google Scholar 

  39. J. Warkany and R. C. Nelson, Skeletal abnormalities in offspring of rats reared on deficient diets, Anat. Rec. 79, 83–100 (1941).

    Article  CAS  Google Scholar 

  40. J. Gillman, C. Gilbert, T. Gillman, and I. Spence, A preliminary report on hydrocephalus, spina bifida, and other congenital anomalies in the rat produced by trypan blue, S. Afr. J. Med. Sci. 13, 47–90 (1948).

    PubMed  CAS  Google Scholar 

  41. H. Kalter and J. Warkany, Congenital malformations in inbred strains of mice induced by riboflavin-deficient, galactoflavin-containing diets, J. Exp. Zool. 136, 531–566 (1957).

    Article  PubMed  CAS  Google Scholar 

  42. H. Kalter and J. Warkany, Experimental production of congenital malformations in strains of inbred mice by maternal treatment with hypervitaminosis A, Am. J. Pathol. 38, 1–21 (1961).

    PubMed  CAS  Google Scholar 

  43. H. Baxter and F. C. Fraser, The production of congenital defects in the offspring of female mice treated with cortisone, McGill Med. J. 19, 245–249 (1950).

    PubMed  CAS  Google Scholar 

  44. J. J. Buresh and T. J. Urban, The teratogenic effect of the steroid nucleus in the rat, J. Dent. Res. 43, 548–554 (1964).

    Article  PubMed  CAS  Google Scholar 

  45. K. M. Massey, Teratogenic effects of diphenylhydantoin sodium, J. Oral Therap. Pharmacol. 2, 380–385 (1966).

    CAS  Google Scholar 

  46. K. T. Szabo, Teratogenicity of lithium in mice, Lancet 2, 849 (1969).

    Article  PubMed  CAS  Google Scholar 

  47. A. J. Bateman, The induction of dominant lethal mutations in rats and mice with triethylenemelamine (TEM), Genet. Res. 1, 381–392 (1960).

    Article  Google Scholar 

  48. B. M. Cattanach, The effect of triethylene-melamine on the fertility of female mice, Internat. J. Radiat. Biol. 3, 288–292 (1959).

    Article  Google Scholar 

  49. G. Röhrborn, Über einen Geschlechtsunterschied in der mutagenen Wirkung von Trenimon bei der Maus, Humangenetik 2, 81–82 (1966).

    Article  PubMed  Google Scholar 

  50. G. Röhrborn and H. Berrang, Dominant lethals in young female mice, Mutation Res. 4, 231–233 (1967).

    Google Scholar 

  51. W. M. Generoso and W. L. Russell, Strain and sex variations in the sensitivity of mice to dominant-lethal induction with ethyl methanesulfonate, Mut. Res. 8, 589–598 (1969).

    CAS  Google Scholar 

  52. C. P. Dagg, in “Biology of the Laboratory Mouse” (E. L. Green, ed.) 2nd ed., pp. 309–328, McGraw-Hill, New York (1966).

    Google Scholar 

  53. M. Smithberg, Teratogenesis in inbred strains of mice, Adv. Teratol. 2, 257–288 (1967).

    Google Scholar 

  54. J. Wilson, Embryological considerations in teratology, Ann. N.Y. Acad. Sci. 123, 219–227 (1965).

    Article  PubMed  CAS  Google Scholar 

  55. J. G. Wilson, Differentiation and reaction of rat embryos to radiation, J. Cell. Comp. Physiol. 43, Suppl., 11–37 (1954).

    Article  CAS  Google Scholar 

  56. L. B. Russell and W. L. Russell, An analysis of the changing radiation response of the developing mouse embryo, J. Cell. Comp. Physiol. 43, Suppl., 103–147 (1954).

    Article  CAS  Google Scholar 

  57. L. B. Russell and M. H. Major, Radiation-induced presumed somatic mutations in the house mouse, Genetics 42, 161–175 (1957).

    PubMed  CAS  Google Scholar 

  58. S. Soukup, E. Takacs, and J. Warkany, Chromosome changes in embryos treated with various teratogens, J. Embryol. Exp. Morphol. 18, 215–228 (1967).

    PubMed  CAS  Google Scholar 

  59. T. H. Ingalls, E. F. Ingenito, and F. J. Curley, Acquired chromosomal anomalies induced in mice by injection of a teratogen in pregnancy, Science 141, 810–812 (1963).

    Article  PubMed  CAS  Google Scholar 

  60. A. Endo and T. H. Ingalls, Chromosomal anomalies in embryos of diabetic mice, Arch. Env. Hlth., 16, 316–325 (1968).

    CAS  Google Scholar 

  61. Commission on Drug Safety, “Report. Conference on Prenatal Effects of Drugs, ” Chicago (1963).

    Google Scholar 

  62. H. Vagtborg, ed., “Use of Nonhuman Primates in Drug Evaluation, ” University of Texas Press, Austin (1968).

    Google Scholar 

  63. C. O. Miller, ed., “Proceedings. Conference on Nonhuman Primate Toxicology, ” U.S. Department of Health, Education, and Welfare, Washington, D.C. (1968).

    Google Scholar 

  64. B. B. Brodie and W. D. Reid, Is man a unique animal in response to drugs? Am. J. Pharm. 141, 21–27 (1969).

    PubMed  CAS  Google Scholar 

  65. J. V. Neel, “Changing Perspectives on the Genetic Effects of Radiation, ” Charles C Thomas, Springfield, Ill. (1963).

    Google Scholar 

  66. J. V. Neel, Atomic bombs, inbreeding, and Japanese genes: The Russel Lecture for 1966, Univ. Mich. Med. Cent. J. 32, 107–116 (1966).

    PubMed  CAS  Google Scholar 

  67. W. J. Schull, J. V. Neel, and A. Hashizume, Some further observations on the sex ratio among infants born to survivors of the atomic bombings of Hiroshima and Nagasaki, Am. J. Hum. Genet. 18, 328–338 (1966).

    PubMed  CAS  Google Scholar 

  68. C. Auerbach and D. S. Falconer, A new mutant in the progeny of mice treated with nitrogen mustard, Nature 163, 678–679 (1949).

    Article  PubMed  CAS  Google Scholar 

  69. R. G. Edwards, The experimental induction of gynogenesis in the mouse. III. Treatment of sperm with trypaflavine, toludine blue, or nitrogen mustard, Proc. Roy. Soc. London, Series B 149, 117–129 (1958).

    Article  CAS  Google Scholar 

  70. B. M. Cattanach, in “Effects of Ionizing Radiation on the Reproductive System” (W. D. Carlson and F. X. Gassner, eds.) pp. 415–431, Macmillan, New York (1964).

    Google Scholar 

  71. D. Haskin, Some effects of nitrogen mustard on the development of external body form in the fetal rat, Anat. Rec. 102, 493–511 (1948).

    Article  PubMed  CAS  Google Scholar 

  72. S. P. Hicks, Some effects of ionizing radiation and metabolic inhibition on developing mammalian nervous system, J. Pediat. 40, 489–513 (1952).

    Article  PubMed  CAS  Google Scholar 

  73. C. H. Danforth and E. Center, Nitrogen mustard as a teratogenic agent in the mouse, Proc. Soc. Exp. Biol. Med. 86, 705–707 (1954).

    PubMed  CAS  Google Scholar 

  74. O. Thalhammer and E. Heller-Szöllösy, Exogene Bildungsfehler (“Missbildungen”) durch Lostinjection bei der graviden Maus, Z. Kinderheilk. 76, 351–365 (1955).

    Article  PubMed  CAS  Google Scholar 

  75. M. L. Murphy and D. A. Karnofsky, Effect of azaserine and other growthinhibiting agents on fetal development of the rat, Cancer 9, 955–962 (1956).

    Article  PubMed  CAS  Google Scholar 

  76. M. L. Murphy, C. P. Dagg, and D. A. Karnofsky, Comparison of teratogenic chemicals in the rat and chick embryos, Pediatrics 19, 701–714 (1957).

    PubMed  CAS  Google Scholar 

  77. H. Nishimura and S. Takagaki, Congenital malformations in mice induced by nitrogen mustard, Acta Schol. Med. Univ. Kioto Jap. 36, 20–26 (1959).

    CAS  Google Scholar 

  78. A. Jurand, Further investigations on the cytotoxic and morphogenetic effects of some nitrogen mustard derivatives, J. Embryol. Exp. Morphol. 9, 492–506 (1961).

    PubMed  CAS  Google Scholar 

  79. R. L. Brent, B. T. Bolden, and J. B. Franklin, The evaluation of teratogenic agents by means of the uterine vascular clamping technique, Am. J. Dis. Child. 104, 464–654, abst. (1962).

    Google Scholar 

  80. M. L. Murphy, Teratogenic effects in rats of growth inhibiting chemicals, including studies on thalidomide, Clin. Proc. Child. Hosp. (Washington, D.C.) 18, 307–322 (1962).

    CAS  Google Scholar 

  81. N. Brock and T. von Kreybig, Experimenteller Beitrag zur Prüfung teratogener Wirkungen von Arzneimitteln an der Laboratoriumsratte, Naunyn- Schmiedebergs Arch. Exp. Pathol. 249, 117–145 (1964).

    Article  CAS  Google Scholar 

  82. M. Müller and N. Škreb, Does nitrogen mustard mimic the X-ray effects in any case? Experientia 20, 70–71 (1964).

    Article  PubMed  Google Scholar 

  83. M. Müller, Does nitrogen mustard affect the foetus directly or secondarily by its effects on the mother? Experientia 22, 247 (1966).

    Article  PubMed  Google Scholar 

  84. R. A. Hettig, G. G. Robertson, and D. T. Cline, Effect of nitrogen mustard injections on the embryos of pregnant rats, J. Lab. Clin. Med. 36, 833–834, abst. (1950).

    PubMed  CAS  Google Scholar 

  85. I. Hayashi, T. Yama, and H. Fujii, Experimental studies on the relationship between embryonic environment and developmental anomalies, Acta Pathol. Jap. 7, 444–445, abst. (1957).

    Google Scholar 

  86. K. Okano, J. Esumi, S. Ito, S. Kashiyama, H. Fujita, T. Toba, and H. Ito, Influences of nitromin on rat embryo, Acta Pathol. Jap. 8, 561, abst. (1958).

    Google Scholar 

  87. A. Jurand, Anti-mesodermal activity of a nitrogen mustard derivative. J. Embryol. Exp. Morphol. 11, 689–696 (1963).

    PubMed  CAS  Google Scholar 

  88. J. Jackson, B. W. Fox, and A. W. Craig, The effect of alkylating agents on male rat fertility, Brit. J. Pharmacol 14, 149–157 (1959).

    PubMed  CAS  Google Scholar 

  89. V. A. Alexandrov, Characteristics of the pathogenic action of sarcolysin on the embryogenesis of rats, Dokl. Akad. Nauk. SSSR 171, 746–749 (1966).

    Google Scholar 

  90. H. Jackson, Antifertility substances, Pharmacol Rev. 11, 135–172 (1959).

    PubMed  CAS  Google Scholar 

  91. K. Didcock, D. Jackson, and J. M. Robson, The action of some nucleotoxic substances on pregnancy, Brit. J. Pharmacol. 11, 437–441 (1956).

    PubMed  CAS  Google Scholar 

  92. I. W. Monie, Chlorambucil-induced abnormalities of the urogenital system of rat fetuses, Anat. Rec. 139, 145–153 (1961).

    Article  PubMed  CAS  Google Scholar 

  93. H. Tuchmann-Duplessis and L. Mercier-Parot, Répercussions des neuroleptiques et des antitumoraux sur le développement prénatal, Bull. Acad. Suisse Sci. Med. 20, 490–526 (1964).

    CAS  Google Scholar 

  94. S. Chaube, G. Kury, and M. L. Murphy, Teratogenic effects of cyclophosphamide (NSC-26271) in the rat, Cancer Chemotherap. Rep. 51, 363–376 (1967).

    Google Scholar 

  95. D. Brittinger, Die mutagene Wirkung von Endoxan bei der Maus, Humangenetik 3, 156–165 (1966).

    Article  PubMed  CAS  Google Scholar 

  96. E. Schleiermacher, Über den Einfluss von Trenimon und Endoxan auf die Meiose der männlichen Maus. II. Cytogenetische Befunde nach Behandlung mit Trenimon und Endoxan, Humangenetik 3, 134–155 (1966).

    Article  PubMed  CAS  Google Scholar 

  97. P. Gerlinger, Action du cyclophosphamide injecté à la mère sur la réalisation de la forme du corps des embryons de lapin, Compt. Rend. Soc. Biol. 158, 2154–2157 (1964).

    CAS  Google Scholar 

  98. P. Gerlinger and J. Clavert, Action du cyclophosphamide injecté à des lapines gestantes sur les gonades embryonnaires, Compt. Rend. Acad. Sci. 258, 2899–2901 (1964).

    CAS  Google Scholar 

  99. P. Gerlinger and J. Clavert, Action du cyclophosphamide injecté à différentes périodes de la gestation sur les cellules sexuelles embryonnaires de lapin, Compt. Rend. Soc. Biol. 158, 2464–2466 (1964).

    CAS  Google Scholar 

  100. P. Gerlinger and J. Clavert, Etude de l’évolution des cellules sexuelles d’embryons issus de lapines traitées au cyclophosphamide, Compt. Rend. Soc. Biol. 159, 1386–1389 (1965).

    CAS  Google Scholar 

  101. P. Gerlinger and J. Clavert, Anomalies observées chez des lapins issues de mères traitées au cyclophosphamide, Compt. Rend. Soc. Biol. 159, 1462–1466 (1965).

    CAS  Google Scholar 

  102. I. Hackenberger and T. von Kreybig, Vergleichende teratologische Untersuchungen bei der Maus und der Ratte, Arzneimittelforschung 15, 1456–1460 (1965).

    PubMed  CAS  Google Scholar 

  103. T. von Kreybig, Die teratogene Wirkung von Cyclophosphamid während der embryonalen Entwicklungsphase bei der Ratte, Naunyn-Schmiedebergs Arch. Exp. Pathol. 252, 173–195 (1965).

    Article  CAS  Google Scholar 

  104. T. von Kreybig, Zür Wirkung von Teratogenen auf frühe Stadien der vorgeburtlichen Entwicklung der Ratte„ Naunyn-Schmiedebergs Arch. Exp. Pathol. 252, 196–204 (1965).

    Article  CAS  Google Scholar 

  105. T. von Kreybig, Extremitätsmissbildungen im Tierexperiment, Arzneimittelforschung 15, 1213–1217 (1965).

    Google Scholar 

  106. R. Shoji and E. Ohzu, Effect of endoxan on developing mouse embryos, J. Fac. Sci. 15, 662–665 (1965).

    CAS  Google Scholar 

  107. T. von Kreybig and W. Schmidt, Zur chemischen Teratogenese bei der Ratte, Arzneimittelforschung 16, 989–1000 (1966).

    CAS  Google Scholar 

  108. T. von Kreybig and W. Schmidt, Chemisch induzierte Fetopathien bei der Ratte. Experimentelle Untersuchungen über die Wirkung von Cyclophosphamid und N-Methyl-N-nitroso-Harnstoff nach der Gabe am 15. oder 16. Tag des Gestation, Arzneimittelforschung 17, 1093–1099 (1967).

    Google Scholar 

  109. J. E. Gibson and B. A. Becker, The teratogenicity of cyclophosphamide in mice, Cancer Res. 28, 475–480 (1968).

    PubMed  CAS  Google Scholar 

  110. J. E. Gibson and B. A. Becker, Effect of phenobarbital and SKF 525-A on the teratogenicity of cyclophosphamide in mice, Teratology 1, 393–398 (1968).

    Article  PubMed  CAS  Google Scholar 

  111. C. E. Adams, M. F. Hay, and C. Lutwak-Mann, The action of various agents upon the rabbit embryo, J. Embryol. Exp. Morphol. 9, 468–491 (1961).

    PubMed  CAS  Google Scholar 

  112. U. H. Ehling, R. B. Cumming, and H. V. Malling, Induction of dominant lethal mutations by alkylating agents in male mice, Mutation Res. 5, 417–428 (1968).

    PubMed  CAS  Google Scholar 

  113. W. M. Generoso, Chemical induction of dominant lethals in female mice, Genetics 61, 461–470 (1969).

    PubMed  CAS  Google Scholar 

  114. H Jackson and M. Bock, The effect of triethylamine on the fertility of rats, Nature 175, 1037–1038 (1955).

    Article  PubMed  CAS  Google Scholar 

  115. M. Bock and H. Jackson, The action of triethylenemelamine on the fertility of male rats, Brit. J. Pharmacol. 12, 1–7 (1957).

    PubMed  CAS  Google Scholar 

  116. B. M. Cattanach and R. G. Edwards, The effects of triethylenemelamine on the fertility of male mice, Proc. Roy. Soc. Edinburgh, Series B, 67, 54–64 (1958).

    CAS  Google Scholar 

  117. E. Steinberger, W. O. Nelson, A. Boccabella, and W. J. Dixon, A radiomimetic effect of triethylenemelamine on reproduction in the male rat, Endocrinology 65, 40–50 (1959).

    Article  PubMed  CAS  Google Scholar 

  118. J. K. Sherman and E. Steinberger, Effect of triethylenemelamine on reproductive capacity of mouse spermatozoa, Proc. Soc. Exp. Biol. Med. 103, 348–350 (1960).

    PubMed  CAS  Google Scholar 

  119. B. M. Cattanach, A chemically-induced variegated-type position effect in the mouse, Z. Vererb. 92, 165–182 (1961).

    Article  CAS  Google Scholar 

  120. B. M. Cattanach, Induction of paternal sex-chromosome losses and deletions and of autosomal gene mutations by the treatment of mouse post-meiotic germ cells with triethylenemelamine, Mutation Res. 4, 73–82 (1967).

    PubMed  CAS  Google Scholar 

  121. B. N. Hemsworth and H. Jackson, in “Embryopathic Activity of Drugs” (J. M. Robson, F. M. Sullivan, and R. L. Smith, eds.) pp. 116–137, Little, Brown, Boston (1965).

    Google Scholar 

  122. S. S. Epstein and H. Shafner, Chemical mutagens in the human environment, Nature 219, 385–386 (1968).

    Article  PubMed  CAS  Google Scholar 

  123. J. B. Thiersch, Effect of 2, 4, 6 triamino-“s”-triazene (TR) 2, 4, 6 “tris” (ethyleneimino)-“s”-triazene (TEM) and N, N′, N″-triethylenephosphoramide (TEPA) on rat litter in utero, Proc. Soc. Exp. Biol. Med. 94, 36–40 (1957).

    PubMed  CAS  Google Scholar 

  124. H. Tuchmann-Duplessis and L. Mercier-Parot, Sur l’action tératogène de quelques substances antimitotiques chez le rat, Compt. Rend. Acad. Sci. 247, 152–154 (1958).

    CAS  Google Scholar 

  125. A. Jurand, Action of triethanomelamine (TEM) on early and late stages of mouse embryos, J. Embryol Exp. Morphol 7, 526–539 (1959).

    PubMed  CAS  Google Scholar 

  126. M. Kageyama, Multiple development anomalies in offspring of albino mice mice injected with triethylenemelamine (TEM) during pregnancy [in Japanese with English summary], Acta Anat. Nippon. 36, 10–23 (1961).

    Google Scholar 

  127. M. Kageyama and H. Nishimura, Developmental anomalies in mouse embryos induced by triethylenemelamine (TEM), Acta Schol. Med. Univ. Kioto Jap. 37, 318–327 (1961).

    CAS  Google Scholar 

  128. S. Sobin, Experimental creation of cardiac defects, Proc. M. R. Pediat. Res. Conf. 14, 13–16 (1955).

    Google Scholar 

  129. N. I. Nuzhdin and G. V. Nizhnik, Fertilization and embryonic development of rabbits following in vitro treatment of spermatozoa with chemical mutagens [in Russian], Dokl. Akad. Nauk. SSSR 181, 224–227 (1968).

    PubMed  CAS  Google Scholar 

  130. K. Okano, H. Fujita, I. Ito, S. Kashiyama, K. Esumi, H. Ito, and T. Toba, Effects of thio-TEPA on fetus of albino rats, Acta Pathol Jap. 9, 644–645 abst. (1959).

    Google Scholar 

  131. T. Tanimura and H. Nishimura, Teratogenic effect of thio-TEPA, a potent antineoplastic compound, upon the offspring of pregnant mice [in Japanese], Acta Anat. Nippon. 37, 66–67 (1962).

    Google Scholar 

  132. H. Nanjo, Maldevelopment of the fetuses caused by maternal administration of thio-TEPA in relation to maternal age [in Japanese with English summary], Acta Anat. Nippon. 39, 258–262 (1964).

    PubMed  CAS  Google Scholar 

  133. M. Nishikawa, Teratogenic effect of combined administration of fasting and thio-TEPA upon mouse embryos [in Japanese with English summary], Acta Anat. Nippon. 39, 252–257 (1964).

    PubMed  CAS  Google Scholar 

  134. K. Takano, T. Tanimura, and H. Nishimura, The susceptibility of the offspring of alloxan-diabetic mice to a teratogen, J. Embryol. Exp. Morphol. 14, 63–73 (1965).

    PubMed  CAS  Google Scholar 

  135. H. Nishimura, M. Terada, and M. Yasuda, Mitigated teratogenicity of thio-TEPA in the goldthioglucose obese mice, Proc. Soc. Exp. Biol. Med. 124, 1190–1193 (1967).

    PubMed  CAS  Google Scholar 

  136. T. Tanimura, Relationship of dosage and time of administration to teratogenic effects of thio-TEPA in mice, Okaj. Folia Anat. Jap. 44, 337–355 (1968).

    CAS  Google Scholar 

  137. T. B. Gaines and R. D. Kimbrough, The sterilizing, carcinogenic and teratogenic effects of metepa in rats, Bull. World Health Org. 34, 317–320 (1966).

    PubMed  CAS  Google Scholar 

  138. G. Röhrborn, Die mutagene Wirkung von Trenimon bei der männlichen Maus, Humangenetik 1, 576–578 (1965).

    Article  PubMed  Google Scholar 

  139. S. Sokół, The influence of the drug Bayer E-39 [Improquone] solubile on the embryonic development of the rat, Folia Biol. 14, 317–330 (1966).

    Google Scholar 

  140. W. Zimmermann and G. H. M. Gottschewski, Die Wirkung bestimmter Substanzen auf die DNS- und Proteinsynthese in der frühen Embryonalentwicklung des Kaninchens, Bull. Schweiz. Akad. Med. Wiss. 22, 166–183 (1966).

    PubMed  CAS  Google Scholar 

  141. R. L. Younger, Probable induction of congenital anomalies in a lamb by apholate, Am. J. Vet. Res. 26, 991–995 (1965).

    PubMed  CAS  Google Scholar 

  142. A. M. Malashenko and I. K. Yegorov, The induction of dominant lethals in inbred mice by ethylene imine [in Russian with summary in English], Genetika 3, 59–67 (1967).

    Google Scholar 

  143. A. M. Malashenko and I. K. Yegorov, The induction of dominant lethals in male mice with ethylene and diethylsulphate [in Russian with summary in English], Genetika 4, 21–27 (1968).

    CAS  Google Scholar 

  144. W. Bollag, Cytostatica in der Schwangerschaft, Schweiz. Med. Woch. 84, 393–395 (1954).

    CAS  Google Scholar 

  145. B. N. Hemsworth and H. Jackson, Effect of busulphan on the developing gonad of the male rat, J. Reprod. Fert. 5, 187–194 (1963).

    Article  CAS  Google Scholar 

  146. B. N. Hemsworth and H. Jackson, Effect of busulphan on the developing ovary in the rat, J. Reprod. Fert. 6, 229–233 (1963).

    Article  CAS  Google Scholar 

  147. M. Partington and H. Jackson, The induction of dominant lethal mutations in rats by alkane sulphonic esters, Genet. Res. 4, 333–345 (1963).

    Article  Google Scholar 

  148. A. E. Light, Additional observations on the effects of busulfan on cataract formation, duration of anesthesia, and reproduction in rats, Toxicol. Appl. Pharmacol. 10, 459–466 (1967).

    Article  PubMed  CAS  Google Scholar 

  149. U. H. Ehling and H. V. Mailing, 1, 4 di(methane-sulfonoxy) butane (Myleran) as a mutagenic agent in mice, Genetics 60, 174–175, abst. (1968).

    Google Scholar 

  150. B. H. Hemsworth and H. Jackson, in “Embryopathic Activity of Drugs” (J. M. Robson, F. M. Sullivan, and R. L. Smith, eds.) pp. 116–137, Little, Brown, Boston (1965).

    Google Scholar 

  151. V. A. Alexandrov, Pathological effect of myelosan on embryogenesis [in Russian], Dokl. Akad. Nauk. SSSR 159, 918–920 (1964).

    Google Scholar 

  152. V. A. Alexandrov, The role of allantois injury in the pathogeny of antenatal death and certain embryopathies in rats treated with myelosane (mylerane). The critical period of allantois development in rats [in Russian], Dokl. Akad. Nauk. SSSR 162, 232–235 (1965).

    Google Scholar 

  153. V. A. Alexandrov, Teratogenous effect of antileukemic drug—myelosan (mileran) on rat embryo [in Russian with English summary], Arkh. Anat. 44, 87–94 (1965).

    Google Scholar 

  154. V. A. Alexandrov, Analysis of the lethal effect of ‘myleran’ on rat embryos, Nature 209, 1215–1216 (1966).

    Article  PubMed  CAS  Google Scholar 

  155. V. A. Alexandrov, Characteristics of disturbance of embryogenesis under the action of myelosan in the early stages of the development of the rat [in Russian], Biull. Eksp. Biol. Med. 61, 81–84 (1966).

    Google Scholar 

  156. J.-G. Forsberg and H. Olivecrona, The effect of prenatally administered busulphan on rat gonads, Biol. Neonat. 10, 180–192 (1966).

    Article  PubMed  CAS  Google Scholar 

  157. Y. Kameyama, T. Sugawara, T. Ogawa, K. Hoshino, and U. Murakami, Effects of myleran on the development of the skeletal system in the rat and mouse embryos, Ann. Rep. Res. Inst. Environ. Med. Nagoya Univ. 14, 61–78 (1966).

    Google Scholar 

  158. B. N. Hemsworth, Embryopathies in the rat due to alkane sulphonates, J. Reprod. Fert. 17, 325–334 (1968).

    Article  CAS  Google Scholar 

  159. H. Jackson, B. W. Fox, and A. W. Craig, Antifertility substances and their assessment in the male rodent, J. Reprod. Fert. 2, 447–465 (1961).

    Article  CAS  Google Scholar 

  160. H. Jackson, M. Partington, and A. L. Walpole, Production of heritable partial sterility in the mouse by methyl methanesulphonate, Brit. J. Pharmacol. Chemotherap. 23, 521–528 (1964).

    CAS  Google Scholar 

  161. M. Partington and A. J. Bateman, Dominant lethal mutations induced in male mice by methylmethanesulphonate, Heredity 19, 191–200 (1964).

    Article  PubMed  CAS  Google Scholar 

  162. B. N. Hemsworth, Effect of alkane sulphonic esters on ovarian development and function in the rat, J. Reprod. Fert. 18, 15–20 (1969).

    Article  CAS  Google Scholar 

  163. B. M. Cattanach, C. E. Pollard, and J. H. Isaacson, Ethyl methanesulfonateinduced chromosome breakage in the mouse, Mutation Res. 6, 297–307 (1968).

    PubMed  CAS  Google Scholar 

  164. U. H. Ehling, D. G. Doherty, and H. V. Malling, Differential mutagenic action of n- and iso-propyl methanesulfonate in mice, Proc. XII Int. Cong. Genet. 1, 103, abst. (1968).

    Google Scholar 

  165. K. H. Baldermann, G. Röhrborn, and T. M. Schroeder, Mutagenitätsuntersuchungen mit Trypaflavin und Hexamethylentetramin am Säuger in vivo und in vitro, Humangenetik 4, 112–126 (1967).

    Article  PubMed  CAS  Google Scholar 

  166. H. F. Hintz, H. Heitman, Jr., A. N. Booth, and W. E. Gagne, Effects of aflatoxin on reproduction in swine, Proc. Soc. Exp. Biol. Med. 126, 146–148 (1967).

    PubMed  CAS  Google Scholar 

  167. J. A. DiPaolo, J. Elis, and H. Erwin, Teratogenic response by hamsters, rats and mice to aflatoxin B1, Nature 215, 638–639 (1967).

    Article  PubMed  CAS  Google Scholar 

  168. R. H. Rigdon and E. G. Rennels, Effect of feeding benzpyrene on reproduction in the rat, Experientia 20, 224–226 (1964).

    Article  PubMed  CAS  Google Scholar 

  169. R. H. Rigdon and J. Neal, Effects of feeding benzo(a)pyrene on fertility, embryos, and young mice, J. Nat. Cancer Inst. 34, 297–306 (1965).

    PubMed  CAS  Google Scholar 

  170. H. Jackson and A. R. Jones, Antifertility action and metabolism of trimethylphosphate in rodents, Nature 220, 591–592 (1968).

    Article  PubMed  CAS  Google Scholar 

  171. G. Röhrborn and F. Vogel, Mutationen durch chemische Einwirkung bei Säuger und Mensch. 2. Genetische Untersuchungen an der Maus, Deut. Med. Woch. 92, 2315–2321 (1967).

    Article  Google Scholar 

  172. M. L. Murphy and S. Chaube, Preliminary survey of hydroxyurea (NSC-32065) as a teratogen, Cancer Chemotherap. Rep. 40, 1–7 (1964).

    CAS  Google Scholar 

  173. M. L. Murphy, in “Teratology: Principles and Techniques” (J. G. Wilson and J. Warkany, eds.) pp. 161–184, University of Chicago Press, Chicago (1965).

    Google Scholar 

  174. V. H. Ferm, Teratogenic activity of hydroxy urea, Lancet 1, 1338–1339 (1965).

    Article  Google Scholar 

  175. V. H. Ferm, Severe developmental malformations. Malformations induced by urethane and hydroxyurea in the hamster, Arch. Pathol. 81, 174–177 (1966).

    Google Scholar 

  176. S. Chaube and M. L. Murphy, The effects of hydroxyurea and related compounds on the rat fetus, Cancer Res. 26, 1448–1457 (1966).

    PubMed  CAS  Google Scholar 

  177. T. von Kreybig, R. Preussmann, and W. Schmidt, Chemische Konstitution und teratogene Wirkung bei der Ratte. I. Carbonsäureamide, Carbonsäurehydrazide und Hydroxamsäuren, Arzneimittelforschung 18, 645–657 (1968).

    Google Scholar 

  178. V. Lauro, F. E. S. Giornelli, A. Fanelli, and C. Giornelli, Inibitori metabolici e fertilità: Indagine sugli effecti dell’idrossiurea nella ratta, Arch. Ostet. Ginec. 73, 451–462 (1968).

    PubMed  CAS  Google Scholar 

  179. R. Roll and F. Bar, Untersuchingen über die teratogene Wirkung von Hydroxyharnstoff während der frühen und embryonalen Entwicklung der Maus, Arch. Toxik. 25, 150–168 (1969).

    Article  PubMed  CAS  Google Scholar 

  180. V. H. Ferm, Teratogenic effect of dimethyl sulphoxide, Lancet 1, 208–209 (1966).

    Article  PubMed  CAS  Google Scholar 

  181. V. H. Ferm, Congenital malformations induced by dimethyl sulphoxide in the golden hamster, J. Embryol. Exp. Morphol. 16, 49–54 (1966).

    PubMed  CAS  Google Scholar 

  182. M. Marin-Padilla, Mesodermal alterations induced by dimethyl sulfoxide, Proc. Soc. Exp. Biol. Med. 122, 717–720 (1966).

    PubMed  CAS  Google Scholar 

  183. F. M. E. Caujolle, D. H. Caujolle, S. B. Cros, and M.-M. J. Calvet, Limits of toxic and teratogenic tolerance of dimethyl sulfoxide, Ann. N. Y. Acad. Sci. 141, 110–125 (1967).

    Article  PubMed  CAS  Google Scholar 

  184. M. B. Juma and R. E. Staples, Effect of maternal administration of dimethyl sulfoxide on the development of rat fetuses, Proc. Soc. Exp. Biol. Med. 125, 566–569 (1967).

    Google Scholar 

  185. J. G. Sinclair, A specific transplacental effect of urethane in mice, Texas Rep. Biol. Med. 8, 623–632 (1950).

    CAS  Google Scholar 

  186. E. K. Hall, Developmental anomalies in the eye of the rat after various experimental procedures, Anat. Rec. 116, 383–394 (1953).

    Article  PubMed  CAS  Google Scholar 

  187. H. Nishimura and M. Kuginuki, Congenital malformations induced by ethylurethan in mouse embryos, Folia Anat. Jap. 31, 1–10 (1958).

    CAS  Google Scholar 

  188. S. L. Kauffman, Early morphologic changes in mouse embryo neural tube following transplacental exposure to urethane, Ped. Proc. 23, 128, abst. (1964).

    Google Scholar 

  189. K. Tsuchikawa and A. Akabori, Differences of the response to teratogens between inbred strains of mice. (1) Differences of the response to ethylurethane between strain CBA and C3HeB/Fe, Proc. Congen. Anom. Res. Ass. Jap. 4, 48, abst. (1964).

    Google Scholar 

  190. K. Tsuchikawa and A. Akabori, Strain differences of susceptibility to induced congenital anomalies in mice, Proc. Congen. Anom. Res. Assoc. Jap. 5, 2, abst. (1964).

    Google Scholar 

  191. S. Takekoshi, Effects of urethan on the teratogenic action of hypervitaminosis A, Gumma J. Med. Sci. 14, 210–212 (1965).

    CAS  Google Scholar 

  192. J. G. Sinclair and B. E. Abreu, Transplacental effects of drugs in mice, Texas Rep. Biol. Med. 23, 849–853 (1965).

    CAS  Google Scholar 

  193. S. Takaori, K. Tanabe, and K. Shimamoto, Developmental abnormalities of skeletal system induced by ethylurethan in the rat, Jap. J. Pharmacol. 16, 63–73 (1966).

    Article  PubMed  CAS  Google Scholar 

  194. T. Tanaka, Postnatal fate of Polydactyly induced by administration of ethylurethane to pregnant mice, Acta Anat. Nippon. 41, 299–305 (1966).

    PubMed  CAS  Google Scholar 

  195. J. A. DiPaolo and J. Elis, Comparison of teratogenic and carcinogenic effects of some carbamate compounds, Cancer Res. 27, 1969–1702 (1967).

    Google Scholar 

  196. S. L. Kauffman and L. Herman, Ultrastructural changes in embryonic mouse neural tube cells after urethane exposure, Dev. Biol. 17, 55–74 (1968).

    Article  PubMed  CAS  Google Scholar 

  197. S. L. Kauffman, Cell proliferation in embryonic mouse neural tube following urethane exposure, Dev. Biol. 20, 146–157 (1969).

    Article  PubMed  CAS  Google Scholar 

  198. S. Peters and M. Strassburg, Stress als teratogener Faktor. Tierexperimentelle Untersuchingen zur Erzeugung von Gaumenspalten, Arzneimittel Forschung 19, 1106–1111 (1969).

    PubMed  CAS  Google Scholar 

  199. N.-J. Höglund, Effects of ethyl urethane on reproduction in mice, Acta Pharmacol. 8, 82–84 (1952).

    Article  Google Scholar 

  200. T. von Kreybig, Verschiedene Wirkmechanismen in teratologischen Experiment, Naunyn-Schmiedebergs Arch. Exp. Pathol. 251, 197–198 (1965).

    Article  Google Scholar 

  201. S. D. Vesselinovitch, N. Mihailovich, and G. Pietra, The prenatal exposure of mice to urethan and the consequent development of tumors in various tissues, Cancer Res. 27, 2333–2337 (1967).

    PubMed  CAS  Google Scholar 

  202. J. A. DiPaolo, Polydactylism in the offspring of mice injected with 5-bromo-deoxyuridine, Science 145, 501–503 (1964).

    Article  PubMed  CAS  Google Scholar 

  203. P. R. Ruffolo and V. H. Ferm, The teratogenicity of 5-bromodeoxyuridine in the pregnant Syrian hamster, Life Sci. 4, 633–637 (1965).

    Article  PubMed  CAS  Google Scholar 

  204. P. R. Ruffolo and V. H. Ferm, The embryocidal and teratogenic effects of 5-bromodeoxyuridine in the pregnant hamster, Lab. Invest. 14, 1547–1553 (1965).

    PubMed  CAS  Google Scholar 

  205. G. Sansone and C. Zunin, Embriopatie sperimentali da deficienza di acido folico nel ratto, prodotte mediante somministrazione di aminopterina, Bull. Soc. Ital. Biol. Sper. 29, 1697–1699 (1953).

    CAS  Google Scholar 

  206. G. Sansone and C. Zunin, Embriopatie sperimentali da somministrazione di antifolico, Acta Vitamin. 8, 73–79 (1954).

    CAS  Google Scholar 

  207. H. J. K. Obbink, Bijdrage tot de kennis omtrent de oorzaken van aangeboren misvormingen van niet-erfelijke oorsprong. Een experimenteel onderzoek bij ratten over het verband tussen foliumzuurdeficientie tijdens de zwangerschap en het onstaan van aangeboren hydrocephalus [in Dutch with English summary], Mededel. Lab. Physiol. Chem. Univ. Amsterdam Ned. Inst. Volksvoed 16, 1–132 (1955–57).

    Google Scholar 

  208. S. Kotani, E. Araki, K. Yukioka, T. Inaba, S. Nakamura, and T. Miyoshi, Experimentally produced congenital anomalies through folic acid deficiency [in Japanese with English summary], J. Osaka City Med. Cent. 7, 353–359 (1958).

    Google Scholar 

  209. C. S. Kinney and L. M. Morse, Effect of a folic acid antagonist, aminopterin, on fetal development and nucleic acid metabolism in the rat, J. Nutr. 84, 288–294 (1964).

    PubMed  CAS  Google Scholar 

  210. V. S. Baranov, The peculiar features of the injuring effect of aminopterin at different stages of rat embryogenesis [in Russian], Dokl. Akad. Nauk. SSSR 163, 1032–1035 (1965).

    PubMed  CAS  Google Scholar 

  211. V. S. Baranov, The specificity of the teratogenic effect of aminopterin as compared to other teratogenic agents [in Russian with English summary], Biull. Eksp. Biol. Med. 61, 77–82 (1966).

    Article  PubMed  CAS  Google Scholar 

  212. L. F. James and R. F. Keeler, Teratogenic effects of aminopterin in sheep, Teratology 1, 407–412 (1968).

    Article  PubMed  CAS  Google Scholar 

  213. J. B. Thiersch and F. S. Philips, Effect of 4-aminopteroylglutamic acid (aminopterin) on early pregnancy, Proc. Soc. Exp. Biol. Med. 74, 204–208 (1950).

    PubMed  CAS  Google Scholar 

  214. M. L. Murphy, Effects of antimetabolites on development of the fetal rat, Am. J. Dis. Child. 96, 533–534, abst. (1958).

    Google Scholar 

  215. M. L. Murphy, in “Teratology: Principles and Techniques” (J. G. Wilson and J. Warkany, eds.) pp. 145–161, University of Chicago Press, Chicago (1965).

    Google Scholar 

  216. N. N. Slonitskaya, Teratogenic effect of griseofulvin-forte on rat fetus [in Russian with English summary], Antibiotiki 14, 44–47 (1969).

    CAS  Google Scholar 

  217. B. M. Cattanach, Lack of effect of nicotine on the fertility of male and female mice, Z. Vererb. 93, 351–355 (1962).

    Article  Google Scholar 

  218. H. Nishimura and K. Nakai, Developmental anomalies in offspring of pregnant mice treated with nicotine, Science 127, 877–878 (1958).

    Article  PubMed  CAS  Google Scholar 

  219. H. Nanjo, Maldevelopment of the fetuses caused by maternal administration of nicotine during pregnancy in relation to maternal age [in Japanese with English summary], Acta. Anat. Nippon. 39, 212–216 (1964).

    PubMed  CAS  Google Scholar 

  220. J. M. Mallette and B. C. Y. Man, Some effects of maternal intake of nicotine on fetal mice, Am. Zool. 6, 611, abst. (1966).

    Google Scholar 

  221. D. Vara and O. Kinnunen, Effect of nicotine on the female rabbit and developing fetus, Ann. Med. Exp. Biol. Fenniae 29, 202–213 (1951).

    CAS  Google Scholar 

  222. L. M. Geller, Failure of nicotine to affect development of offspring when administered to pregnant rats, Science 129, 212–214 (1959).

    Article  PubMed  CAS  Google Scholar 

  223. H. D. Mosier and M. K. Armstrong, Effects of maternal intake of nicotine on fetal and newborn rats, Proc. Soc. Exp. Blol. Med. 116, 956–958 (1964).

    CAS  Google Scholar 

  224. R. Becker, J. E. King, and C. R. D. Little, Delayed birth in experimental animals and its relation to the postmaturity syndrome, Anat. Rec. 154, 315, abst. (1966).

    Google Scholar 

  225. H. D. Mosier, Jr., and M. K. Armstrong, Effect of maternal nicotine intake on fetal weight and length in rats, Proc. Soc. Exp. Biol. Med. 124, 1135–1137 (1967).

    PubMed  CAS  Google Scholar 

  226. M. F. Lyon, R. J. S. Phillips, and A. G. Searle, A test for mutagenicity of caffeine in mice, Z. Vererb. 93, 7–13 (1962).

    CAS  Google Scholar 

  227. B. M. Cattanach, Genetical effects of caffeine in mice, Z. Vererb. 93, 215–219 (1962).

    Article  CAS  Google Scholar 

  228. W. Kuhlmann, H. Fromme, E. Heege, and W. Ostertag, The mutagenic action of caffeine in higher organisms, Cancer Res. 28, 2375–2389 (1968).

    PubMed  CAS  Google Scholar 

  229. I. D. Adler, Does caffeine induce dominant lethal mutations in mice? Humangenetik 7, 137–148 (1969).

    Article  PubMed  CAS  Google Scholar 

  230. H. Nishimura and K. Nakai, Congenital malformations in offspring of mice treated with caffeine, Proc. Soc. Exp. Biol. Med. 104, 140–142 (1960).

    PubMed  CAS  Google Scholar 

  231. C. Knoche and J. König, Zur pränatalen Toxizität von Diphenylpyralin-8-chlor-theophyllinat unter Berücksichtigung von Erfahrungen mit Thalidomid und Koffein, Arzneimittel Forschung 14, 415–424 (1964).

    PubMed  CAS  Google Scholar 

  232. M. Bertrand, E. Schwam, A. Frandon, A. Vagne, and J. Alary, Sur un effet tératogène systématique et spécifique de la caféine chez les rongeurs, Compt. Rend. Soc. Biol. 159, 2199–2202 (1965).

    CAS  Google Scholar 

  233. T. Fujii, H. Sasaki, and H. Nishimura, Teratogenicity of caffeine in mice related to its mode of administration, Jap. J. Pharmacol. 19, 134–138 (1969).

    Article  PubMed  CAS  Google Scholar 

  234. A. Georges and J. Denef, Les anomalies digitales: Manifestations tératogéni-ques des dérivés xanthiques chez le rat, Arch. Internat. Pharmacodyn. Thérap. 172, 219–222 (1968).

    CAS  Google Scholar 

  235. B. K. Batra, The effect of methylcholanthrene painting of the ovaries on the progeny of mice, Acta Union Internat. Contra. Cancer 15, 128–133 (1959).

    CAS  Google Scholar 

  236. S. Fabro, R. L. Smith, and R. T. Williams, Embryotoxic activity of some pesticides and drugs related to phthalimide, Food Cosmetol. Toxicol. 3, 587–590 (1965).

    Article  CAS  Google Scholar 

  237. G. Kennedy, O. E. Fancher, and J. C. Calandra, An investigation of the teratogenic potential of captan, folpet and difolatan, Toxicol. Appl. Pharmacol. 13, 420–430 (1968).

    Article  PubMed  CAS  Google Scholar 

  238. Y. Chambon, Action de la chlorpromazine sur l’évolution et l’avenir de la gestation chez le rat, Ann. Endocrinol. 16, 912–922 (1955).

    CAS  Google Scholar 

  239. F. Bovet-Nitti and D. Bovet, Action of some sympatholytic agents on pregnancy in the rat, Proc. Soc. Exp. Biol. Med. 100, 555–557 (1959).

    PubMed  CAS  Google Scholar 

  240. O. D. Murphree, B. L. Monroe, and L. D. Seager, Survival of offspring of of rats administered phenothiazines during pregnancy, J. Neuropsychiat. 3, 295–297 (1962).

    CAS  Google Scholar 

  241. J. M. Ordy, A. Latanick, R. Johnson, and L. Massopust, Chlorpromazine effects on pregnancy and offspring in mice, Proc. Soc. Exp. Biol. Med. 113, 833–866 (1963).

    PubMed  CAS  Google Scholar 

  242. C. Rolsten, Effects of chlorpromazine and psilocin on pregnancy of C57BL/10 mice and their offspring at birth, Anat. Rec. 157, 311, abst. (1967).

    Google Scholar 

  243. S. Ranström, Stress and pregnancy, Acta Pathol. Microbiol. Scand. Suppl. 111, 113–114 (1956).

    Google Scholar 

  244. L. B. Schnürer, Maternal and foetal responses to chronic stress in pregnancy, Acta Endocrinol. Suppl. 80, 1–96 (1963).

    Google Scholar 

  245. D. J. Clegg, Absence of teratogenic effect of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) in rats and mice, Food Cosmetol. Toxicol. 3, 387–403 (1965).

    Article  CAS  Google Scholar 

  246. M. C. Chang, Artificial production of monstrosities in the rabbit, Nature 154, 150 (1944).

    Article  Google Scholar 

  247. R. G. Edwards, Colchicine-induced heteroploidy in the mouse. I. The induction of triploidy by treatment of the gametes, J. Exp. Zool. 137, 317–348 (1958).

    Article  PubMed  CAS  Google Scholar 

  248. J. H. Van Dyke and M. G. Ritchey, Colchicine influence during embryonic development in rats, Anat. Rec. 97, 375, abst. (1947).

    Google Scholar 

  249. B. P. Wiesner, M. Wolfe, and J. Yudkin, The effects of some antimitotic compounds on pregnancy in the mouse, Studies Fert. 9, 129–136 (1958).

    CAS  Google Scholar 

  250. V. H. Ferm, Colchicine teratogenesis in hamster embryos, Proc. Soc. Exp. Biol. Med. 112, 775–778 (1963).

    PubMed  CAS  Google Scholar 

  251. V. H. Ferm, Effect of transplacental mitotic inhibitors on the fetal hamster eye, Anat. Rec. 148, 129–138 (1964).

    Article  PubMed  CAS  Google Scholar 

  252. V. H. Ferm, The rapid detection of teratogenic activity, Lab. Invest. 14, 1500–1505 (1965).

    PubMed  CAS  Google Scholar 

  253. R. Shoji and S. Makino, Preliminary notes on the teratogenic and embryocidal effects of colchicine on mouse embryos, Proc. Jap. Acad. 42, 822–827 (1966).

    CAS  Google Scholar 

  254. G. L. Vankin and H. J. Grass, Colcemid-induced teratogenesis in hybrid mouse embryos, Am. Zool. 6, 551, abst. (1966).

    Google Scholar 

  255. J. M. Morris, G. van Wagenen, G. D. Hurteau, D. W. Johnston, and R. A. Carlsen, Compounds interfering with ovum implantation and development. I. Alkaloids and antimetabolites, Fert. Ster. 18, 7–17 (1967).

    CAS  Google Scholar 

  256. T. H. Ingalls, F. J. Curley, and P. Zappasodi, Colchicine-induced craniofacial defects in the mouse embryo, Arch. Environ. Health 16, 326–332 (1967).

    Google Scholar 

  257. T. Kerr, On the effects of colchicine treatment of mouse embryos, Proc. Zool. Soc. London 116, 551–564 (1947).

    Google Scholar 

  258. C. H. Conaway, Embryo resorption and placental scar formation in the rat, J. Mammalol. 36, 516–532 (1955).

    Article  Google Scholar 

  259. J. B. Thiersch, Effect of N-desacetyl thio colchicine (TC) and N-desacetylmethyl-colchicine (MC) on rat fetus and litter in utero, Proc. Soc. Exp. Biol. Med. 98, 479–485 (1958).

    PubMed  CAS  Google Scholar 

  260. W. Gibel, E. Geibler, K. H. Lohs, H. Hilscher, G. P. Wildner, and S. Wittbrodt, Untersuchungen zur Frage einer möglichen mutagenen Wirkung von Fuselöl, Arch. Geschwulstforsch. 33, 49–54 (1969).

    PubMed  CAS  Google Scholar 

  261. A. V. Bespamyatnova, S. D. Zaugalnikov. and Yu. Z. Sukhov, Embryotoxic and teratogenic action of ethylene-imine [in Russian with English summary]. Farmakol. Toksik. 33, 357–360 (1970).

    CAS  Google Scholar 

  262. E. Le Breton, C. Frayssment, C. Lafarge, and A. M. De Recondo. Aflatoxine—mécanisme de l’action, Food Cosm. Toxic. 2, 674–677 (1964).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Children’s Hospital Research Foundation and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA

    Harold Kalter

Authors
  1. Harold Kalter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Biology, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA

    Alexander Hollaender

Rights and permissions

Reprints and permissions

Copyright information

© 1971 Plenum Press, New York

About this chapter

Cite this chapter

Kalter, H. (1971). Correlation Between Teratogenic and Mutagenic Effects of Chemicals in Mammals. In: Hollaender, A. (eds) Chemical Mutagens. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-8966-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-8966-2_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-8968-6

  • Online ISBN: 978-1-4615-8966-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation